EUVIMEDEUVIMED entdecken
Crossref

Myelodysplastic Syndromes (MDS); diagnosis, classification, treatment and monitoring

Maryam Panahi, Mahmoud Dehghani Ghorbi, Mozhgan Amirpour, Reika Nayebi, Bentol Hoda Kuhestani Dehaghi

Iranian Journal of Blood and Cancer · 2022

DOI: 10.58209/ijbc.14.3.71 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iranian Journal of Blood and Cancer, 2022. Verfasst von Maryam Panahi und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Panahi, M., Ghorbi, M. D., Amirpour, M., Nayebi, R., & Dehaghi, B. H. K. (2022). Myelodysplastic Syndromes (MDS); diagnosis, classification, treatment and monitoring. Iranian Journal of Blood and Cancer. https://doi.org/10.58209/ijbc.14.3.71

Vancouver

Panahi M, Ghorbi MD, Amirpour M, Nayebi R, Dehaghi BHK. Myelodysplastic Syndromes (MDS); diagnosis, classification, treatment and monitoring. Iranian Journal of Blood and Cancer. 2022. doi:10.58209/ijbc.14.3.71

BibTeX
@article{Panahi2022,
  author = {Panahi, Maryam and Ghorbi, Mahmoud Dehghani and Amirpour, Mozhgan and Nayebi, Reika and Dehaghi, Bentol Hoda Kuhestani},
  title = {Myelodysplastic Syndromes (MDS); diagnosis, classification, treatment and monitoring},
  journal = {Iranian Journal of Blood and Cancer},
  year = {2022},
  doi = {10.58209/ijbc.14.3.71}
}
Kostenlos starten →